Free Trial

Baxter International (BAX) Competitors

Baxter International logo
$32.63 +0.11 (+0.34%)
(As of 11/20/2024 ET)

BAX vs. BDX, EW, RMD, IDXX, DXCM, STE, PODD, HOLX, GMED, and TFX

Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Globus Medical (GMED), and Teleflex (TFX). These companies are all part of the "health care equipment" industry.

Baxter International vs.

Becton, Dickinson and Company (NYSE:BDX) and Baxter International (NYSE:BAX) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, community ranking, earnings, risk, institutional ownership, dividends and valuation.

Becton, Dickinson and Company has a net margin of 8.55% compared to Baxter International's net margin of 0.77%. Baxter International's return on equity of 18.30% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company8.55% 14.89% 6.98%
Baxter International 0.77%18.30%5.43%

Baxter International has lower revenue, but higher earnings than Becton, Dickinson and Company. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$20.18B3.19$1.73B$5.9437.44
Baxter International$14.81B1.12$2.66B$0.20163.16

Becton, Dickinson and Company has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.

Becton, Dickinson and Company currently has a consensus price target of $283.00, indicating a potential upside of 27.25%. Baxter International has a consensus price target of $40.91, indicating a potential upside of 25.37%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, equities research analysts clearly believe Becton, Dickinson and Company is more favorable than Baxter International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00
Baxter International
1 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.18

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 0.3% of Becton, Dickinson and Company shares are owned by insiders. Comparatively, 0.2% of Baxter International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Baxter International received 136 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 65.68% of users gave Baxter International an outperform vote while only 62.38% of users gave Becton, Dickinson and Company an outperform vote.

CompanyUnderperformOutperform
Becton, Dickinson and CompanyOutperform Votes
597
62.38%
Underperform Votes
360
37.62%
Baxter InternationalOutperform Votes
733
65.68%
Underperform Votes
383
34.32%

Becton, Dickinson and Company pays an annual dividend of $3.80 per share and has a dividend yield of 1.7%. Baxter International pays an annual dividend of $1.16 per share and has a dividend yield of 3.6%. Becton, Dickinson and Company pays out 64.0% of its earnings in the form of a dividend. Baxter International pays out 580.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Becton, Dickinson and Company has increased its dividend for 53 consecutive years.

In the previous week, Becton, Dickinson and Company had 22 more articles in the media than Baxter International. MarketBeat recorded 32 mentions for Becton, Dickinson and Company and 10 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 1.42 beat Baxter International's score of 0.14 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
27 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Baxter International
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Becton, Dickinson and Company beats Baxter International on 13 of the 21 factors compared between the two stocks.

Get Baxter International News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAX vs. The Competition

MetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$16.60B$4.47B$5.07B$19.96B
Dividend Yield3.57%36.79%4.99%3.49%
P/E Ratio163.1613.2787.8636.42
Price / Sales1.1244.831,228.8217.94
Price / Cash6.2052.2739.5121.28
Price / Book2.105.776.944.59
Net Income$2.66B$13.76M$119.12M$985.93M
7 Day Performance2.90%-1.10%-1.84%0.45%
1 Month Performance-10.77%0.56%-3.65%1.05%
1 Year Performance-8.60%50.90%31.64%24.67%

Baxter International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAX
Baxter International
4.8179 of 5 stars
$32.63
+0.3%
$40.91
+25.4%
-8.4%$16.60B$14.81B163.1660,000
BDX
Becton, Dickinson and Company
4.9899 of 5 stars
$222.41
-0.1%
$283.00
+27.2%
-4.8%$64.35B$20.18B37.4473,000Positive News
EW
Edwards Lifesciences
4.1267 of 5 stars
$69.54
-0.9%
$75.67
+8.8%
+3.5%$41.40B$6.00B10.0319,800Short Interest ↓
Analyst Revision
RMD
ResMed
4.7999 of 5 stars
$241.55
+1.4%
$225.70
-6.6%
+59.7%$34.96B$4.69B31.999,980Positive News
IDXX
IDEXX Laboratories
4.8685 of 5 stars
$418.61
+0.5%
$552.38
+32.0%
-11.5%$34.09B$3.66B40.3711,000Positive News
DXCM
DexCom
4.9841 of 5 stars
$75.24
+0.5%
$104.59
+39.0%
-30.9%$29.25B$3.62B45.059,600
STE
STERIS
4.9928 of 5 stars
$212.25
+0.1%
$253.00
+19.2%
+6.2%$20.93B$5.14B48.4618,179Analyst Forecast
Positive News
PODD
Insulet
4.3848 of 5 stars
$266.58
+1.8%
$253.27
-5.0%
+47.1%$18.38B$1.70B45.653,000
HOLX
Hologic
4.8594 of 5 stars
$78.04
-0.7%
$89.91
+15.2%
+8.5%$18.25B$4.03B23.446,990
GMED
Globus Medical
4.487 of 5 stars
$83.58
+0.3%
$88.18
+5.5%
+84.2%$11.35B$1.57B124.755,000Analyst Downgrade
Positive News
TFX
Teleflex
4.8737 of 5 stars
$187.47
-2.9%
$259.25
+38.3%
-12.7%$8.97B$2.97B37.2714,500Analyst Downgrade

Related Companies and Tools


This page (NYSE:BAX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners